Autism is a heterogeneous condition that is likely to result from the combined effects of multiple genetic factors interacting with environmental factors. Given its complexity, the study of autism associated with Mendelian single gene disorders or known chromosomal etiologies provides an important perspective. We used microarray analysis to compare the mRNA expression profile in lymphoblastoid cells from males with autism due to a fragile X mutation (FMR1-FM), or a 15q11-q13 duplication (dup(15q)), and non-autistic controls. Gene expression profiles clearly distinguished autism from controls and separated individuals with autism based on their genetic etiology. We identified sixty-eight genes that were dysregulated in common between autism with FMR1-FM and dup(15q). We also identified a potential molecular link between FMR1-FM and dup(15q), the cytoplasmic FMR1 interacting protein 1 (CYFIP1), which was up-regulated in dup(15q) patients. We were able to confirm this link in vitro by showing common regulation of two other dysregulated genes, JAKMIP1 and GPR155, downstream of FMR1 or CYFIP1. We also confirmed the reduction of the Jakmip1 protein in Fmr1 knock-out mice, demonstrating in vivo relevance. Finally, we showed independent confirmation of roles for JAKMIP1 and GPR155 in autism spectrum disorders (ASD) by showing their differential expression in male sib pairs discordant for idiopathic ASD. These results provide evidence that blood derived lymphoblastoid cells gene expression is likely to be useful for identifying etiological subsets of autism and exploring its pathophysiology.
INTRODUCTION
Genetic factors are significant determinants of autism spectrum disorders (ASD) pathophysiology (1) (2) (3) (4) . Yet, identification of causal genes has been hampered by genetic and phenotypic heterogeneity (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Thus, it seems reasonable to accelerate the gene discovery process by using combinations of experimental approaches, such as the study of "single gene" or more simple causes, such as chromosomal copy number imbalances whose phenotypes include ASD (1) (2) (3) (4) . One such disorder is fragile X syndrome (FXS) (1) (2) (3) (4) 19) , which is caused by an expansion of the trinucleotide repetitive sequence (CGG)n in the promoter region of the fragile X mental retardation 1 (FMR1) gene located at Xq27. 3 (20) . This mutation causes a significant deficit of the FMR1 protein (FMRP) and a phenotype including cognitive impairment and other behavioral abnormalities that overlap with ASD. The prevalence of ASD among FXS cases has been estimated at 15-33% (21, 22) and approximately 1% to 3% of those with autism and no obvious physical features of FXS are found to have FMR1-FM (19, 23) .
Another disorder associated with susceptibility for ASD is a maternally inherited duplication of 15q11-q13 (dup(15q)) (1) (2) (3) (4) 24) . Multiple repeat elements within the region mediate a variety of rearrangements, including interstitial duplications, interstitial triplications, and supernumerary isodicentric marker chromosomes (25). Dup(15q) occurs with an estimated frequency of 1:600 children with developmental delay (26) and is the most common copy number variation causing ASD (3, 24) . Several lines of evidence (24, 27) suggest that dysregulation of non-imprinted genes in the duplicated region and/or throughout the whole genome may contribute to the autistic phenotype observed in dup(15q).
Therefore, we reasoned that the identification of genes whose expression is dysregulated by both FMR1-FM and dup(15q) may be relevant to ASD, since the two genetic abnormalities represent cases where single mutations, either a trinucleotide repeat or copy number variation (28), cause ASD. We also wanted to examine, as a proof of principle, whether lymphoblast gene expression profiles identified by microarrays could differentiate these single mutation "simple" causes of autism from each other and controls. This would provide a basis for further application of these methods in idiopathic autism, where more multigenic inheritance and environmental influences may be involved (1) (2) (3) (4) .
Recently, several studies have suggested that lymphoblastoid cells can be used to detect biologically plausible correlations between candidate genes and neuropsychiatric diseases, including Rett syndrome (29), nonspecific X-linked mental retardation (30), bipolar disorder (31), FXS (32) and dup(15q) (27) . In the present study, we investigated whether gene expression profiles of lymphoblastoid cells could be used to: 1) differentiate autistic subjects who were ascertained and diagnosed as having ASD in the Autism Genetic Resource Exchange (AGRE) (33) repository into etiological categories (FMR1-FM and dup(15q)), and 2) identify common genes and pathways shared by FMR1-FM and dup(15q) that might be relevant to autism pathophysiology. Here, we demonstrate that gene expression profiles were able to clearly distinguish individuals based on their etiology. We also identified 68 genes dysregulated in both autism with FMR1-FM and dup(15q). Interestingly, we identified a molecular connection between FMR1-FM and dup(15q), CYFIP1, which was significantly induced in dup(15q) and is known to antagonize certain aspects of FMRP function (34). We further demonstrated that the expression of janus kinase and microtuble interacting protein 1 (JAKMIP1) and G protein-coupled receptor 155 (GPR155) were commonly dysregulated by the reduction of FMR1 or induction of CYFIP1 in vitro. The expression of Jakmip1 was also dysregulated in the brain of the Fmr1 knock-out mouse. Finally, we were able to show that JAKMIP1 and GPR155 were dysregulated in males with autism spectrum disorders (ASD) relative to their non-affected siblings, providing independent confirmation to suggest these genes are associated with ASD.
RESULTS

Hierarchical clustering and principal component analysis distinguished individuals based on genetic etiology
We analyzed the whole-genome mRNA expression profile in lymphoblastoid cells from 15 autistic males (8 autistic males with FMR1-FM and 7 autistic males with dup(15q)) and 15 non-autistic control males from AGRE (Supplemental Table S1 ) using Agilent Whole Genome Human Microarrays. Overall, of 41,000 probes analyzed, 31,044 probes, representing 23,822 genes, were expressed in the lymphoblastoid cells. To find genes that were differentially expressed across the three subject groups, the expression profile of the lymphoblastoid cells was subjected to Analysis of Variance (ANOVA) (35). The ANOVA identified 293 probes (277 genes) below a defined false discovery rate (FDR) threshold of 5% (Supplemental Table S2 ). It has been shown that the expression of FMR1 is decreased in lymphoblastoid cells with FMR1-FM (36) and that the expression of UBE3A is increased in lymphoblastoid cells with dup(15q) (37). Concordant with these reports, FMR1 and UBE3A were among the 293 differentially expressed probes, providing independent controls for the microarray analysis.
As shown in Figures 1A and B, hierarchical clustering using the 293 probes clearly classified individuals based on their genotype. The 293 probes were also subjected to principal component analysis (PCA). As shown in Figure 1C , three dominant PCA components that contained 70% of the variance in the data matrix clearly separated individuals based on genetic etiology. In this plot, the first principal component axis accounted for 56% of the variance in the data set and clearly separated autism with FMR1-FM and dup(15q) from controls, whereas the second principal component (PC2) accounted for 10% of the variance and segregated autism with FMR1-FM from autism with dup(15q). The top 10 genes contributing to PC2 include FMR1, UBE3A, CYFIP1, non-imprinted in Prader-Willi/Angelman syndrome 2 (NIPA2), and hect domain and RLD 2 (HERC2). The latter four genes are all located in 15q11-q13. These results suggest that the selective reduction of FMR1 and the selective induction of the four genes located in 15q11-q13 differentiated autism with FMR1-FM from autism with dup(15q). These data provide a critical proof of principle that the gene expression profile of lymphoblastoid cells is useful in the study of autism.
Microarray analyses revealed the significant overlap of FMR1-FM and dup(15q)
To identify the set of the most robustly differentially expressed genes in each group, we applied three different statistical methods, ANOVA, Significant Analysis of Microarray (SAM) (38) and Rank Product Analysis (RankProd) (39). SAM is a modified t-test statistic, whereas
RankProd is a non-parametric statistic that detects items that are consistently highly ranked in a number of lists. SAM identified 5139 probes and 1281 probes as significant (FDR<5%) in autism with FMR1-FM and dup(15q), respectively (Figures 2A and 2B, Supplemental Tables   S3 and S4 Eighty-three probes representing 68 genes were dysregulated in both autism with FMR1-FM and with dup(15q) ( Table 1 ). This degree of overlap was highly significant (hypergeometric probability, P=1.2 x 10 -153 ). Fifty-two genes and 12 genes were selectively dysregulated in either autism with FMR1-FM and autism with dup(15q), respectively ( Table 2) .
qRTPCR confirmed the differential expression identified by the microarray analysis
To validate the differential expression identified by microarray analysis using independent methods, we performed quantitative real-time PCR analysis (qRTPCR) of 19 genes chosen as a cross-section using the same samples used in the microarray analysis. The qRTPCR confirmed that 17 of the 19 genes were differentially expressed as expected by the microarray analysis ( Figure 3 , A-C). There was an overall highly significant correlation between microarray and qRTPCR results (Pearson correlation, r=0.57, P<0.0001).
CYFIP1 was one of the genes selectively induced in autism with dup(15q). Because CYFIP1 is known to antagonize FMRP (34), we reasoned that the induction of CYFIP1 in dup(15q) might explain some of the significant overlap between autism with FMR1-FM and with dup(15q). JAKMIP1, also known as MARLIN-1, was significantly induced in autism with FMR1-FM and had a positive trend in autism with dup(15q) (P=0.062), suggesting that JAKMIP1 could represent a commonly dysregulated pathway. In fact, RankProd identified JAKMIP1 as a significantly up-regulated gene in dup(15q) by microarray analysis (Supplemental Table S6 ). This gene is a particularly biologically important candidate, given its putative role in GABA B receptor expression (40) and microtubule networks (41).
Functional annotation revealed pathway dysregulation
In an attempt to uncover the common functional meanings among the differentially expressed genes, we classified genes into gene ontology groups using DAVID (42). Table 3 shows the top three clusters identified by DAVID using the 68 genes dysregulated in autism with FMR1-FM and dup(15q) or the 52 genes selectively dysregulated in autism with FMR1-FM. The number of genes selectively dysregulated in autism with dup(15q) was too small to analyze using the functional annotation clustering.
Genes related to cell communication (P=7.6 x 10 -6 ) and signal transduction (P=2.2 x 10 -5 )
were most significantly enriched in the 68 genes commonly dysregulated in autism with Although we identified dysregulated genes in autism with FMR1-FM and dup(15q) using lymphoblastoid cells, we were interested in whether the expression of these genes would also be dependent on FMR1 and CYFIP1 in neuronal cells. To examine the effect of FMR1 and CYFIP1 in neuronal cells, we used the well-characterized human neuronal cell line SH-SY5Y
(45). FMR1 and CYFIP1 dependence in SH-SY5Y cells was assessed using a short hairpin RNA (shRNA) to reduce the expression of FMR1 and a plasmid expression vector to induce the expression of CYFIP1, respectively. As shown in Figure 4A , the expression of FMR1 was reduced to about 60% of its normal level in SH-SY5Y cells stably expressing FMR1 shRNAs, whereas the expression of CYFIP1 was significantly induced (11-fold) in SH-SY5Y cells stably transfected with the CYFIP1 plasmid.
We were able to further demonstrate the effect of down-regulation of FMR1 and upregulation of CYFIP1 on the expression of two key downstream genes ( Figure 4B ). In SH-SY5Y cells transfected with FMR1 shRNA, the expression of JAKMIP1 and GPR155 was significantly reduced and induced, respectively. In SH-SY5Y cells over-expressing CYFIP1, the expression of JAKMIP1 and GPR155 was also reduced and induced, respectively. These findings demonstrated that the expression of JAKMIP1 and GPR155 was also dependent on FMR1 and CYFIP1 in SH-SY5Y cells and that reduction of FMR1 and induction of CYFIP1
can share common downstream effects on the expression of JAKMIP1 and GPR155.
The expression of JAKMIP1 protein was dependent on FMR1 and CYFIP1
We next validated the effect of FMR1 or CYFIP1 on the protein expression of JAKMIP1 in the central nervous system (CNS). We examined the expression of the JAKMIP1 protein in the cortex of Fmr1 knock-out (KO) and wild-type (WT) mice and SH-SY5Y cells transfected with the CYFIP1 over-expression plasmid. The expression of Jakmip1 was reduced in the cortex of Fmr1 KO mice ( Figure 5A ) and SH-SY5Y cells over-expressing CYFIP1 ( Figure   5B ). These results confirmed the in vitro findings that the expression of Jakmip1 was dependent on Fmr1 in mouse brain, suggesting that at least some of the changes observed in lymphoblastoid cells reflect similar changes in the CNS.
The expression of JAKMIP1 and GPR155 was significantly different between 27 male sib pairs discordant for idiopathic ASD To determine the potential generalizability of these findings to idiopathic autism, we examined whether the expression of JAKMIP1 and GPR155 was also dysregulated in lymphoblastoid cells from idiopathic ASD cases. We selected 27 male sib pairs discordant for ASD from AGRE (Supplemental Table S1 ). The 27 males with ASD did not have FMR1-FM or dup(15q) and had surrogate IQ markers (Raven's progressive matrices) >70. As shown in Figure 6 , the expression of JAKMIP1 and GPR155 was significantly dysregulated in the 27 males with ASD when compared with their sibs without ASD. These results show that the dysregulation of JAKMIP1 and GPR155 is associated with ASD. The lack of general intellectual disability in this ASD group also shows that these dysregulations are not simply due to a non-specific cognitive impairment or intellectual disability observed in FXS and In this study, we performed global mRNA expression profiling in males with autism carrying either FMR1-FM or dup(15q) and in control males. We found that these autistic individuals can be differentiated based on their genetic etiologies based on lymphoblast gene expression profiles. Interestingly, this analysis also revealed a common gene expression signature across these two distinct genetic conditions that was significantly different from control profiles. We used the intersection of three different statistical tests to identify the most robustly differentially expressed genes (35, 38, 39), and the qRTPCR data confirmed this gene selection strategy.
Gene expression profiles of lymphoblastoid cells carrying the FMR1-FM
We identified 120 genes differentially expressed in FMR1-FM carriers compared to controls. Among these genes, NR3C1 and VIM were previously identified as target RNAs of The initial study (32) whose primary aim was to find FMRP ligand mRNPs was relatively underpowered to detect overall differences in gene expression and our study used very conservative statistical criteria. However, this core set of genes provides an interesting gene list for further investigation.
Gene expression profiles of lymphoblastoid cells with dup(15q)
We identified 80 genes differentially expressed in dup(15q) carriers compared to controls.
Among these genes, four genes located in 15q11-q13 (the region of duplication) UBE3A, CYFIP1, NIPA2, and GOLGA8F were all induced. It is important to note that five other genes located in the duplicated region, tubulin gamma complex associated protein 5 (TUBGCP5), HERC2, HERC2 pseudogene 2 (HERC2P2), NIPA1, and ATP10A were also identified as upregulated genes by at least one of the three different statistical analyses (Supplemental Table S7 ). Five other genes in the duplicated region, gamma-aminobutyric acid A receptor (GABR) beta 3 (GABRB3), GABR alpha 5 (GABRA5), GABR gamma 3 (GABRG3), oculocutaneous albinism II (OCA2) and necdin homolog (NDN), were not expressed at detectable levels in the lymphoblastoid cells. It is important to emphasize that the 15q11-q13 region is subject to paternal imprinting. Three paternally imprinted genes, makorin ring finger protein 3 (MKRN3), MAGE-like 2 (MAGEL2), and SNRPN upstream reading frame (SNURF)-small nuclear ribonucleoprotein polypeptide N (SNRPN) were expressed in the lymphoblasts, but showed no significant changes relative to controls. These data are consistent with the fact that the duplicated region was maternally derived in all seven cases analyzed in this study. So, overall, these findings suggest that the genes located in the duplicated region were globally upregulated except for the paternally imprinted genes. Global up-regulation due to gene-dosage has also been reported in Down syndrome (50, 51). 
Significant overlap of dysregulated genes in autism with FMR1-FM and dup(15q)
We identified 68 genes that were dysregulated in both autism with FMR1-FM and with dup(15q), a very significant result (the hypergeometric probability of this overlap is 1.2x10 -153 ). However, we can not formally exclude the possibility that some of the 68 common dysregulated genes might be related to common pathways between FMR-FM and dup (15q) unrelated to ASD. Microarray analysis using lymphoblastoid cells with FMR1-FM or dup(15q), but without ASD is needed to exclude the possibility, as was done in tuberous sclerosis cases with and without autism (51).
We found that the expression of CYFIP1 was significantly induced in autism with dup(15q). CYFIP1 has been shown to antagonize FMRP in the eye and nervous system of The expression of JAKMIP1 and GPR155 was also dysregulated in 27 males with idiopathic ASD
The findings in autism with FMR1-FM and dup(15q) suggest that JAKMIP1 and GPR155 may be involved more generally in idiopathic ASD, since their dysregulation is observed in neural cells and brain. We tested whether dysregulation of these genes were more generalizable in an independent sample of idiopathic ASD cases. To attempt to reduce the heterogeneity of idiopathic ASD and extend these findings beyond those with mental retardation or intellectual disability, we used an IQ surrogate based on Raven's Progressive Matrices, which is highly correlated with IQ defined by other measures (62) . We selected 27 ASD males with an IQ score of more than 70. These data demonstrated that the expression of JAKMIP1 and GPR155 was significantly dysregulated in lymphoblastoid cells from idiopathic ASD when compared with controls. These results based on independent data on lymphoblastoid cell gene expression from ASD subjects with FMR1-FM, or dup(15q), as well as idiopathic ASD, suggest that JAKMIP1
and GPR155 may be useful as biomarkers for ASD. In this sample overall, JAKMIP1 appeared to be more robustly dysregulated than GPR155, although the expression differences appeared heterogeneous. How the dysregulation of these genes relates to distinct autism subtypes will also be important to determine in the future.
The mechanism for the opposite regulation of JAKMIP1 and GPR155 in lymphobastoid cells and neural cells remains unclear. There are several previous reports of genes showing the opposite expression between lymphoblastoid cells and brains in neuropsychiatric disease. One example is inositol monophosphatase 2 (IMPA2), which has been identified as a plausible locus for bipolar disorder (63) (64) (65) . The expression of IMPA2 was reduced and induced in lymphoblastoid cells and brains, respectively, in patients with bipolar disorder (66) . A genetic association between IMPA2 promoter polymorphism and bipolar disorder has been confirmed (67, 68) . In this regard, it is notable that GPR155 is located on 2q31.1, 300 kb from D2S2188, which has shown strong linkage to autism in studies by two independent groups (6, 69).
Association analyses for GPR155 and JAKMIP1 are ongoing using the large AGRE cohort.
These data provide the first identification and independent validation of the roles of JAKMIP1
and GPR155 dysregulation in ASD (Figure 7 ). Further work is needed to understand the functional consequences of these changes in the developing brain and to assess the general utility of these and other genes as potential biomarkers.
MATERIALS AND METHODS
Individuals and lymphoblastoid cells analyzed in this study
We have analyzed individuals diagnosed with ASD using standard validated measures, including the Autism Diagnostic Interview (ADI-R) (70) Table S1 ). Surrogate IQ scores (using the Raven Progressive Matrices) were available. FMR1-FM and dup(15q) were examined by PCR and fluorescence in situ hybridization, respectively. The 15q11-q13 duplicated regions in the seven males analyzed in this study were all maternally derived. We also used 14 other individuals from AGRE for common reference (pool) in microarray analysis (data not shown). Lymphoblastoid cell lines (human Epstein-Barr virus transformed lymphocytes) from these individuals were available from AGRE and NIGMS cell repositories.
The lymphoblastoid cells of the subjects were grown in RPMI 1640 medium with 2 mM L-glutamine and 25 mM HEPES (Invitrogen, Carlsbad, CA, USA), 10% fetal bovine serum, and 1xAntibiotic-Antimycotic solution (Invitrogen) at 37 o C in a humidified 5% CO 2 chamber.
Cells were grown to a density of 6 x 10 5 /ml. Special attention was given to maintain all the cell lines in the same conditions to minimize environmental variation.
Microarray experiments
A total of 9 x 10 6 of lymphoblastoid cells were seeded in a T-75 flask in 30 ml of fresh medium. After 24 hours, total RNA was extracted from the cells using an RNeasy Mini Kit with DNase treatment (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol.
The RNA quantity and quality were measured by ND-100 (Nanodrop, Wilmington, DE, USA) and 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA), respectively.
Target preparation was performed using a Low RNA Input Fluorescent Linear Amplification Kit (Agilent) according to the manufacturer's protocol. We extracted total RNA from lymphoblastoid cells from each individual and made target and labeled it with Cy5 fluorescence. We also made reference target by using pooled total RNA from the 14 individuals for reference and labeled it with Cy3 fluorescence. The generated targets were mixed and subjected to hybridization to the Whole Human Genome Array G4112A (Agilent) according to the manufacturer's protocol. Scanning of the microarrays were done by a DNA microarray scanner (Agilent).
Scanner output image files were normalized and filtered using Feature Extraction Software v8.5 (Agilent). Normalization was performed so that overall intensity ratio of Cy5 to
Cy3 was equal to one. Probes with signal-to-noise ratio >2.7 in both Cy3 and Cy5 in at least 14 of 15 controls were used for further analysis.
Statistical analysis of microarray data
ANOVA was performed by MeV3.1 (72) . P values were calculated based on 1000 permutations. Hierarchical clustering using Spearman's rank correlation with average linkage clustering was performed by MeV3.1 Principal component analysis was performed using 
Quantitative real time PCR analysis (qRTPCR)
One µg of total RNA was used to make cDNA by SuperScript III First-Strand Synthesis SuperMix (Invitrogen). The qRTPCR was done by ABI Prism 7900 (Applied Biosystems, Foster City, CA, USA) using Platinum SYBR Green qPCR SuperMix UDG with ROX (Invitrogen). Thermal cycling consisted of an initial step at 50 o C for 2 min followed by another step at 95 o C for 2 min and 50 cycles of 95 o C for 15 sec and 60 o C for 30 sec. The qRTPCR was performed for 16 genes. The primers used in this study are shown in Supplementary Table S8 . TaqMan probe (Hs00327005_m1, Applied Biosystems) was used to measure JAKMIP1 expression in lymphoblastoid cells. Data were normalized by the quantity of hypoxanthine phosphoribosyltransferase 1 (HPRT1). HPRT1 was selected rather than betaactin, glyceraldehyde-3-phosphate dehydrogenase or other possible internal controls because it was shown to be most stable RNA species from the lymphoblastoid cell lines. This allowed us to account for the variability in the conversion efficiency of the reverse transcription reaction.
Transduction of retroviral shRNAs
To construct retrovirus vectors expressing shRNAs, oligonucleotides encoding stem-loop shRNAs for FMR1 (Supplemental Table S8 ) and negative control were ligated into the BamHI 
Animals and tissue collection
Wild-type (WT) and Fmr1 KO mice were raised at the Emory University animal facility and treated in accordance with National Institue of Health regulations and under approval of the Emory University Institutional Animal Care and Use Committee. Wild type and Fmr1 KO littermates were produced by breeding heterozygous females with FMR1 KO males in a congenic background of C57BL/6. The genotype of each animal was confirmed by PCR. For tissue collection, cortices were dissected and protein was isolated using Cellytic M (Sigma) with proteinase inhibitors (Sigma) according to the manufacturer's protocol.
Immunoblot analysis
Proteins extracted from SH-SY5Y cells or cortices of Fmr1 WT and KO mice were Total RNA was extracted from lymphoblastoid cells of 27 male sib pairs discordant for ASD and qRTPCR were performed to confirm the differential expression of JAKMIP1 and GPR155.
Results represent means ± S.D. of each group. The mean of the value of control subjects was set as 1. P-value was calculated by Wilcoxon rank-sum test using control (N=27) vs. ASD (N=27). *p<0.05 
